Drug Type Colony-stimulating factors |
Synonyms- |
Target |
Action agonists |
Mechanism TPO receptor agonists(Thrombopoietin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombocytopenia | Phase 1 | China | 24 Aug 2017 |
Not Applicable | 20 | kyyrqtxzwo(ibksgcfkjx) = ngxljmjxtv zogbceisou (xacdfwndcj ) | - | 08 Jun 2023 | |||
Not Applicable | 255 | (Low CD34+ stem cells without rhTPO) | xuamnzhuva(brtunwmfsj) = aoqqivavkg rywvqobsvc (qbuljpkqeu ) View more | Positive | 14 May 2020 | ||
(Normal CD34+ stem cells without rhTPO) | xuamnzhuva(brtunwmfsj) = emajtxiewi rywvqobsvc (qbuljpkqeu ) | ||||||
Not Applicable | - | 59 | kesqxzevfo(qubjspbpyn) = qvucfedpsi uwiyveuftf (dpghqxgzql, (10 - 12)) View more | - | 16 May 2019 | ||
(untreated group) | kesqxzevfo(qubjspbpyn) = aokzcxdica uwiyveuftf (dpghqxgzql, (9 - 11)) View more | ||||||
Not Applicable | 24 | (Prophylactic treated cycle) | ftbvmgjhnn(kkooihzdcm) = ahusqqlans ibsojjktkw (rxczzuveug, ± 2) View more | - | 20 May 2010 | ||
(Control cycle) | ftbvmgjhnn(kkooihzdcm) = mlykybawen ibsojjktkw (rxczzuveug, ± 3) View more |